Publication: Late re-activation of Coats disease
0
0
Issued Date
2019
Resource Type
File Type
application/pdf
ISSN
24519936
Other identifier(s)
2-s2.0-85065230637
Rights Holder(s)
Scopus
Bibliographic Citation
American Journal of Ophthalmology Case Reports. Vol 15, (2019)
Suggested Citation
Lertjirachai I., Wood E.H., Moinuddin O., Drenser K.A. Late re-activation of Coats disease. American Journal of Ophthalmology Case Reports. Vol 15, (2019). doi:10.1016/j.ajoc.2019.100458 Retrieved from: https://hdl.handle.net/20.500.14740/5175
Author(s)
Abstract
Purpose: To report case of Coats disease with the longest known interval of disease quiescence prior to first reactivation (17 years). Observation: A 25-year-old male was regularly followed for Coats disease since age 4. After initial treatment with cryoablation, disease quiescence was achieved at age 8. The disease activity was well controlled for 17 years after which he developed decreased vision in the right eye at age 25. Late reactivation of Coats disease was diagnosed and multiple treatments ensued. Despite aggressive therapy, the patient experienced progressive exudation warranting surgical management and eventually developed neovascular glaucoma. Conclusion: Once diagnosed with Coats disease, lifelong monitoring is essential to early detection and treatment of potential disease reactivation. The interval between disease quiescence and reactivation is variable, with this case representing the longest known interval of disease quiescence prior to first reactivation (17 years). © 2019 The Authors
Subject(s)
Antiglaucoma agent
Ranibizumab
Steroid
Triamcinolone acetonide
Vasculotropin
Vasculotropin antibody
Adult
Article
B scan
Best corrected visual acuity
Case report
Clinical article
Cryoablation
Disease course
Disease exacerbation
Exudative retinitis
Follow up
Human
Intraocular pressure
Lensectomy
Male
Neovascular glaucoma
Optical coherence tomography
Pars plana vitrectomy
Recurrent disease
Retina detachment
Retina fluorescein angiography
Subcapsular cataract
Subtenon drug administration
Ranibizumab
Steroid
Triamcinolone acetonide
Vasculotropin
Vasculotropin antibody
Adult
Article
B scan
Best corrected visual acuity
Case report
Clinical article
Cryoablation
Disease course
Disease exacerbation
Exudative retinitis
Follow up
Human
Intraocular pressure
Lensectomy
Male
Neovascular glaucoma
Optical coherence tomography
Pars plana vitrectomy
Recurrent disease
Retina detachment
Retina fluorescein angiography
Subcapsular cataract
Subtenon drug administration